<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02772939</url>
  </required_header>
  <id_info>
    <org_study_id>Effectiveness0001</org_study_id>
    <nct_id>NCT02772939</nct_id>
  </id_info>
  <brief_title>Arterial Stiffness as a Predictor of Response to Renal Sympathetic Denervation</brief_title>
  <acronym>EFFECTIVENES</acronym>
  <official_title>Evaluation of Arterial Stiffness as a Predictor of Response to Renal Sympathetic Denervation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Leipzig</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Leipzig</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This trial is designed to establish invasive and non-invasive measures of arterial stiffness
      as potential predictors of treatment response to renal sympathetic denervation
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Regardless of the ongoing debate on the general effect of renal sympathetic denervation in
      therapy resistant hypertension, all trials published so far face the problem of a certain
      proportion of nonresponders to treatment. Previous data shows, that to some extent this might
      be attributable to arterial stiffening. Elevated invasive pulse wave velocity as an
      established marker for arterial stiffness has been found to be associated with nonresponse to
      renal denervation treatment in a smaller trial population. This trial attempts to assess the
      predictive value of different invasive and non-invasive markers for arterial stiffness in an
      adequately powered population.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2015</start_date>
  <completion_date type="Anticipated">September 2018</completion_date>
  <primary_completion_date type="Anticipated">June 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Predictive value of noninvasive and invasive measures of arterial stiffness (Pulse wave velocity and central pulse pressure assessed invasively, with a piezoelectric device and MRI-based)</measure>
    <time_frame>3 Months</time_frame>
    <description>AUC of ROCs for noninvasive and invasive measures of arterial stiffness in predicting response to renal denervation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in 24h ambulatory blood pressure</measure>
    <time_frame>3 months, 6 months, 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in exercise blood pressure</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Predictive value of MRI-assessed aortic distensibility on Change in daytime ambulatory blood pressure</measure>
    <time_frame>3 months, 6 months, 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Predictive value of MRI-assessed aortic distensibility on Change in 24 h ambulatory blood pressure</measure>
    <time_frame>3 months, 6 months, 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Predictive value of MRI-assessed total arterial compliance on Change in daytime ambulatory blood pressure</measure>
    <time_frame>3 months, 6 months, 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Predictive value of MRI-assessed total arterial compliance on Change in 24 h ambulatory blood pressure</measure>
    <time_frame>3 months, 6 months, 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>comparison of predictive value of invasive pulse wave velocity, invasive central pulse pressure, noninvasive pulse wave velocity, noninvasive central pulse pressure, aortic distensibility, total arterial compliance for Change in ambulatory blood pressure</measure>
    <time_frame>3 months, 6 months, 12 months</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Therapy Resistant Arterial Hypertension</condition>
  <arm_group>
    <arm_group_label>Renal Denervation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Renal denervation for therapy resistant arterial hypertension</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Renal sympathetic denervation (RDN)</intervention_name>
    <description>Catheter based renal sympathetic denervation for therapy resistant arterial hypertension</description>
    <arm_group_label>Renal Denervation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with therapy resistant arterial hypertension (&gt;=3 antihypertensive drugs
             including at least one diuretic without any dosage change in the preceding 4 weeks)
             and office BP &gt;160 mmHg systolic or 90 mmHg diastolic

        Exclusion Criteria:

          -  average systolic daytime BP &lt;135 mmHg in 24h ambulatory blood pressure measurement
             (ABPM)

          -  pregnancy

          -  known renal artery stenosis

          -  &gt;= 1 renal artery diameter &lt; 4 mm

          -  life expectancy &lt;6 months

          -  participation in any other clinical trial
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Heart Center of the University Leipzig</name>
      <address>
        <city>Leipzig</city>
        <zip>04289</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Philipp Lurz, MD, PhD</last_name>
      <phone>+49341865252022</phone>
      <email>Philipp.Lurz@gmx.de</email>
    </contact>
    <investigator>
      <last_name>Philipp Lurz, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 10, 2016</study_first_submitted>
  <study_first_submitted_qc>May 11, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 16, 2016</study_first_posted>
  <last_update_submitted>May 7, 2017</last_update_submitted>
  <last_update_submitted_qc>May 7, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 9, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Leipzig</investigator_affiliation>
    <investigator_full_name>Philipp Lurz</investigator_full_name>
    <investigator_title>Philipp Lurz, PhD, MD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

